摘要
纤维肌痛(FM)是一种以慢性广泛性疼痛伴疲劳、睡眠障碍和认知功能障碍为症状的普遍疾病。最近的研究表明,双相谱系障碍常常与个体的纤维肌痛同时发生。此外,共同的病理生理机制预测了纤维肌痛和双相情感障碍之间显著现象学相似。全面的英语文献检索通过2015年5月10日在Pubmed / MEDLINE数据库颁布实施。以确定独特的关于流行病学与纤维肌痛和双相情感障碍之间的共同病理生理学的参考文献。重叠的神经回路,可以支持并行两种疾病的临床表现。纤维肌痛和双相情感障碍都是以下丘脑-垂体-肾上腺轴功能异常,炎症介质水平升高、氧化和亚硝化应激和线粒体功能障碍为特征的。两种疾病的犬尿氨酸途径的激活驱动了色氨酸远离血清素和褪黑激素的产生,导致情感症状、昼夜节律紊乱和疼痛处理异常。此外,这两种疾病均与受损的神经可塑性相关(例如,改变脑源性神经营养因子的信号)。对纤维肌痛和双相情感障碍之间的症状和病理生理学的认识已有相关的病因、临床和治疗意义并值得今后的进一步研究。
关键词: 双相情感障碍、纤维肌痛、炎症、氧化应激、脑源性神经营养因子,下丘脑-垂体-肾上腺轴、神经影像学、病理生理学、精神病学、神经病学。
Current Molecular Medicine
Title:Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology
Volume: 16 Issue: 2
Author(s): B. Bortolato, M. Berk, M. Maes, R.S. McIntyre and A.F. Carvalho
Affiliation:
关键词: 双相情感障碍、纤维肌痛、炎症、氧化应激、脑源性神经营养因子,下丘脑-垂体-肾上腺轴、神经影像学、病理生理学、精神病学、神经病学。
摘要: Fibromyalgia (FM) is a prevalent disorder defined by the presence of chronic widespread pain in association with fatigue, sleep disturbances and cognitive dysfunction. Recent studies indicate that bipolar spectrum disorders frequently co-occur in individuals with FM. Furthermore, shared pathophysiological mechanisms anticipate remarkable phenomenological similarities between FM and BD. A comprehensive search of the English literature was carried out in the Pubmed/MEDLINE database through May 10th, 2015 to identify unique references pertaining to the epidemiology and shared pathophysiology between FM and bipolar disorder (BD). Overlapping neural circuits may underpin parallel clinical manifestations of both disorders. Fibromyalgia and BD are both characterized by functional abnormalities in the hypothalamic-pituitary-adrenal axis, higher levels of inflammatory mediators, oxidative and nitrosative stress as well as mitochondrial dysfunction. An over-activation of the kynurenine pathway in both illnesses drives tryptophan away from the production of serotonin and melatonin, leading to affective symptoms, circadian rhythm disturbances and abnormalities in pain processing. In addition, both disorders are associated with impaired neuroplasticity (e.g., altered brain-derived neurotrophic factor signaling). The recognition of the symptomatic and pathophysiological overlaping between FM and bipolar spectrum disorders has relevant etiological, clinical and therapeutic implications that deserve future research consideration.
Export Options
About this article
Cite this article as:
B. Bortolato, M. Berk, M. Maes, R.S. McIntyre and A.F. Carvalho , Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology, Current Molecular Medicine 2016; 16 (2) . https://dx.doi.org/10.2174/1566524016666160126144027
DOI https://dx.doi.org/10.2174/1566524016666160126144027 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin
Current Pharmaceutical Design Molecular Imaging of Stem Cell Transplantation for Neurodegenerative Diseases
Current Pharmaceutical Design Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus
Current Pharmaceutical Design Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis
Current Pharmaceutical Design Synthesis and Evaluation of Thiazolidinedione-Coumarin Adducts as Antidiabetic, Anti-Inflammatory and Antioxidant Agents
Letters in Organic Chemistry The Role of Tec Family Kinases in Inflammatory Processes
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inflammatory Signaling Networks as Targets for Pharmacological Intervention of Chronic Diseases
Current Signal Transduction Therapy Differentiation of iNKT Cells from Embryonic Stem Cells
Current Immunology Reviews (Discontinued) The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Aptamers as Innovative Diagnostic and Therapeutic Agents in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Synaptic Activity-Regulated Wnt Signaling in Synaptic Plasticity, Glial Function and Chronic Pain
CNS & Neurological Disorders - Drug Targets Novel Anti-Inflammatory and Neuroprotective Agents for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Activation of the Liver X Receptor Inhibits Th17 and Th1 Responses in Behcet`s Disease and Vogt-Koyanagi-Harada Disease
Current Molecular Medicine A Translational View of Peptide Treatment of Neurological Disorders
Current Medicinal Chemistry Immunological Mechanisms of Neuropsychiatric Lupus
Current Immunology Reviews (Discontinued) Autoimmune Channelopathies of the Nervous System
Current Neuropharmacology Ex Vivo Gene Therapy and Vision
Current Gene Therapy Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry Correlating Low-Similarity Peptide Sequences and Allergenic Epitopes
Current Pharmaceutical Design